• No se han encontrado resultados

LA EMPRESA DE AGUA POTABLE, Y ASEO

CONCLUSIONES Y RECOMENDACIONES.

xxxix Apgar score <7

in 5minutes 21 (36.8) 9 (15.8) 6.514 0.011 2.33 (1.71-4.65)

Neonatal intensive care unit admission

>24hours

12 (21.1) 6 (10.5) 2.375 0.123 2.00 (0.81-4.96)

Intrapartum fetal

death 1 (1.8) 0 (0.0) 0.000 1.000∞

Early neonatal death 5 (8.8) 1 (1.8) 1.583 0.208∞ 5.00 (0.60-41.47)

Birth weight <2.5kg 6 (10.5) 0 (0.0) 4.398 0.036∞

Normal outcome

25 (43.9) 41 (71.9) 9.212 0.002 2.00 (1.24-3.22)

B AFI: borderline AFI. N AFI: normal AFI. RR: relative risk. CI: confidence interval

∞: Yates’ continuity correction applied.

With respect to perinatal outcome as shown in Table 3, Intrapartum fetal distress (p = 0.035, RR = 2.29, CI = 1.02-8.13), Apgar score <7 in 5minutes (p = 0.011, RR = 2.33, CI = 1.71-4.65) and birthweight <2.5kg (p = 0.036) occurred more frequently in the borderline AFI group, this is statistically significant (p < 0.05) which disproves the null hypothesis of this study. Meconium stained liquor, Neonatal intensive care unit admission >24hours,

intrapartum fetal death and early neonatal death also occurred more frequently in the

borderline AFI group. However, this was not statistically significant (p > 0.05) and confirms the null hypothesis.

CHAPTER 6

xl gestational age, a comparison of the two groups for statistical significance was done to assess the effectiveness of the matching process. This showed that there was no statistically significant difference in the pattern of demographic variables such as maternal age, parity group, gestational age at study entry and gestational age at admission for delivery between the normal and borderline amniotic fluid index groups. This demonstrates that the impact of probable confounding variables had been reduced to the minimum. Biosocial variables are commonly seen as confounding in health research. While randomization is the best way of controlling for bias and confounders, matching has been shown to be very useful too when there are suspicions of likely confounders49–52. The comparison of the exposed and non-exposed groups demonstrated its efficacy in this study.

The results of this study showed that mode of delivery such as spontaneous labour, induction of labour, assisted vaginal delivery, antepartum caesarean section, and intrapartum caesarean section were statistically significantly higher in the borderline AFI group.

Parturients with borderline AFI in this study were statistically significantly more likely to undergo induction of labour with a relative risk of 2.08. This was similar to findings from studies by Asgharnia et al1, Gumus et al 22 and Choi 30. Asgharnia and colleagues1 (2013) compared women with normal and borderline AFI in the third trimester. Since women with borderline AFI are more likely to have induction of labour, there is an attendant increase in both maternal and neonatal morbidity and mortality. Induction of labour is associated with a higher risk of interventions such as caesarean sections, assisted vaginal delivery, ruptured uterus, postpartum haemorrhage as well as increased duration and cost of hospital care53. Babies may also end up with morbidities such as neurological deficits due to birth asphyxia from fetal distress54.

In this study, parturients with borderline AFI were thrice as likely to have assisted vaginal delivery (vacuum extraction or forceps delivery) compared to those with normal AFI.

xli This difference was statistically significant. This is in contrast to all previous findings on this theme. Gumus et al22 (2007) found no association between borderline AFI and assisted vaginal delivery. Theirs was a retrospective study involving women with singleton, uncomplicated, non-anomalous gestations, who underwent weekly monitoring of amniotic fluid index until delivery during the last trimester and who gave birth at their hospital.

Yaqoob et al37 (2009), Mahapatro et al39 (2013) and Wood et al38 (2014) also did not establish significant association in their studies.

The implication of the statistical significance of assisted vaginal delivery in women with borderline AFI is that there might be an increased need for obstetric personnel at the delivery of these women, increased incidence of birth trauma (both maternal and fetal) and increased Neonatal intensive care services. Also of public health importance is a reduction in the caesarean section rate. It is known that a reduction in primary caesarean section reduces the overall caesarean section rate55. Asides this, there is a negative attitude and strong aversion towards caesarean section amongst women in low-income countries including Nigeria as they prefer a vaginal delivery56. Assisted vaginal delivery is also one of the critical functions of basic and comprehensive emergency obstetric recommended by WHO57, and also reduces the overall cost of delivery.

In this study, parturients with borderline AFI were three times more likely to undergo caesarean delivery when compared to their normal AFI counterparts. This was statistically significant. Similar findings have been reported by Petrozella et al28, Kwon et al 29 and Jamal et al33. However, the findings of Choi et al30, Yaqoob et al37, and Wood et al38 are in contrast with the findings of this study. Differences may be due to the facts that these studies were retrospective studies. In addition, in the study by Choi et al30, the ratio of normal to borderline AFI was 5:1.This may also partly explain the difference in findings. The increased likelihood of women with borderline AFI having caesarean delivery (both antepartum and

xlii intrapartum) increases the risks of complications such as anaesthetic risks, organ injury, need for blood transfusions, infections, as well as the risk of mortality58.

A major finding of this study was that women with borderline AFI had a statistically significant, more than twice higher risk of intrapartum fetal distress and Apgar <7 in 5minutes . Parturients in the borderline AFI group were also statistically significantly more likely to have babies with birthweight <2.5kg. The finding in this study that the occurrence of intrapartum fetal distress was statistically significantly higher in the borderline AFI group is in keeping with that of previous studies by Gumus et al22 (2007) , Jeng et al34 (1992) and Ulker and Ozdemir36 (2011). Wood et al. 38(2014) , Rutherford et al.21 (1987) and Banks et al23 (1999) , in their studies however had contrary findings .They found no statistically significant difference in the rate of fetal intolerance of labour in pregnancies with a borderline AFI compared to those with a normal AFI. The study by Woods et al38was a retrospective study with an approximately 5:1 ratio for normal to borderline AFI.

Considering the fact that fetal distress is more likely to occur in pregnancies with borderline AFI, the wide ratio between groups might be responsible for the absence of statistical significance. Intrapartum fetal distress occurring more amongst the babies whose mothers had borderline AFI increases the chances of the babies being born by assisted vaginal deliveries and also the attendant risks of birth traumas. They are also at a higher risk of respiratory morbidities such as transient tachypnoea of the new born and NICU admissions59.

Apgar score of 0–3 at 5 minutes or more is regarded as a nonspecific sign of illness, which may be one of the first indications of encephalopathy54. A low 5-minute Apgar score clearly confers an increased relative risk of cerebral palsy, reported to be as high as 20-fold to 100-fold over that of infants with a 5-minute Apgar score of 7–1060. The difference in rates of

xliii occurrence of 5th minute Apgar scores less than 7 between borderline and normal AFI groups in this study was statistically significant. Women with borderline AFI had babies who were two times more likely to have 5th minute Apgar scores less than 7. This finding was in keeping with previous studies of Kwon et al28 (2006), Gumus et al22 (2007) and Asgharnia et al1 (2015). However, the findings of a study by Banks and Miller are at variance with the findings of this study. It is likely that the fact that their study population included women with preterm and post term pregnancies would explain the different findings.

Birthweight may be influenced by several factors during pregnancy, one of which is liquor volume61. In this study, there was statistically significant difference between both study groups in terms of birthweight < 2.5kg. This is in line with the findings of several studies.1,22,23,28–30,39. This finding was however in contrast with the study by Baron et al (1995)27 in a retrospective study involving patients with gestational age ≥ 26 weeks who had an intrapartum amniotic fluid index performed with subsequent delivery. Due to the fact that in Baron’s study, patients were recruited during labour, events during the antepartum period which may have had an effect on their findings could not be established.

In a similar vein, Jamal et al33 (2008),looked at borderline amniotic fluid index and adverse perinatal outcome. They did not establish any statistically significant association between birthweight < 2.5kg and borderline amniotic fluid index. The fact that this was a retrospective study which compared 5 normal AFI parturients to 1 borderline AFI might explain the contrary finding. The clinical implication of the borderline AFI parturients having an increased relative risk of babies with birth weight <2.5 kg is that these babies have a greater risk of morbidity and mortality. They will require more expert care given by the paediatricians, increased hospital stay and cost, prone to neonatal infections, hypoglycaemia and othercomplications62.

xliv The strengths of this study include its prospective design, and matching of the possible confounding variables which increases the chance that the findings of the study are valid and generalizable to similar study population in Nigeria. The use of dedicated outcome personnel also minimises inter-observers’ error and ensured accurate outcome data for the variables of interest.

The study is not without limitations. The use of cardiotocography alone for the diagnosis of intrapartum hypoxia without the benefit of confirmatory modalities like fetal scalp blood sampling, fetal scalp lactate, fetal pulse oximetry and fetal electrocardiograph (ST- Analyzer or STAN) may have affected the rate of intervention in labour. However, since both arms of the study had CTG monitoring when indicated, the differential effect on any of the two arms is expected to be minimal. Also, the use of algorithms to assess and record what is normal, what requires more careful attention and what is considered abnormal requiring immediate delivery of the baby minimized inter and intra observer variations in CTG trace interpretation 4546. Another limitation encountered is bias introduced by intra observer error with regards to sonographic determination of AFI. Significant intra observer variability is known to exist in the sonographic evaluation of the gravid uterus47. This has been shown to be the case even in the best of hands, as ultrasound evaluation is highly operator and machine dependent. However, the impact this might have on the study is likely minimal as the investigator was part of the scanning of all the patients studied.

Consequent upon national industrial strike actions, some of the study participants were lost to follow up. However, this was overcome by recruitment of fresh participants and extension of the study period.

CONCLUSION

In this study, more women with normal AFI had spontaneous labour. There was a

xlv statistically significantly higher difference in women with borderline AFI with respect to modes of delivery such as spontaneous labour, induction of labour, assisted vaginal delivery and caesarean delivery. This was in addition to perinatal outcomes such as intrapartum fetal distress, Apgar score < 7 in 5 minutes and birthweight < 2.5kg.

However , this study did not show any statistically significant difference between proportions of the perinatal outcome measures such as meconium stained liquor, Neonatal intensive care unit admission >24hours, Intra partum fetal death and early neonatal death.

RECOMMENDATION

xlvi 1. The available evidence from this study suggests the increased risk of adverse pregnancy outcomes in low risk Nigerian women with borderline AFI such as induction of labour, assisted vaginal delivery, caesarean section, intrapartum fetal distress, Apgar score < 7 in 5 minutes and birthweight < 2.5kg. As such, due to the lack of a definite care protocol and specific decision about delivery for these patients, there is thus a need for the establishment and formulation of protocols on the management of these patients with borderline AFI whereby closer observation and increased antepartum surveillance be instituted in order to avoid adverse perinatal outcome.

2. Based on the fact that the prospective cohort design of this study which allowed for control of possible confounding variables was utilized, it is most likely that the findings were representative of those in the general population. However, randomized controlled studies may be helpful in further confirming the findings.

REFERENCES

1. Asgharnia M, Faraji R, Salamat F, Ashrafkhani B, Dalil Heirati SF, Naimian S.

Perinatal outcomes of pregnancies with borderline versus normal amniotic fluid index.

Iran J Reprod Med. 2013;11(9):705–10.

xlvii 2. Sharaf AH. Assessment of amniotic fluid index in normal pregnancy at a tertiary care

hospital setting. J Ayub Med Coll Abbottabad. 2009;21(3):149–51.

3. Chama CM, Bobzom DN MM. A longitudinal study of amniotic fluid index in normal pregnancy in Nigerian women. Int J Gynecol Obstet. 2001;72(3):223–7.

4. Karim R, Jabeen S, Pervaiz F, Wahab S, Yasmeen S, Raees M. Decreased amniotic fluid index and adverse pregnancy outcome at term. JPMI - J Postgrad Med Inst.

2010;24(4):307–11.

5. Voxman EG, Tran S, Wing DA. Low amniotic fluid index as a predictor of adverse perinatal outcome. J Perinatol. 2002;22(4):282–5.

6. Jandial C, Gupta S, Sharma S, Gupta M. Perinatal outcome after antepartum diagnosis of oligohydramnios at or beyond 34 weeks of gestation. JK Sci. 2007;9(4):213–4.

7. Pankaj D, Purvi P, Anjali G. Decreased amniotic fluid volume in low risk pregnancy:

Any Significance? J Obs Gynecol Ind. 2004;54(5):464–6.

8. Beall MH, Van den Wijngaard JPHM, Van Gemert MJC, Ross MG. Amniotic Fluid Water Dynamics. Placenta. 2007;28(8-9):816–23.

9. Tasneem SA, Kolur A, Ali MK. A Study of Amniotic Fluid Index in Term Pregnancy.

Int J Curr Res Aca Rev. 2014;2(11):147–52.

10. Beall MH, van den Wijngaard JPHM, van Gemert MJC, Ross MG. Regulation of Amniotic Fluid Volume. Placenta. 2007;28(8-9):824–32.

11. Dubi EA, Magann EF. Amniotic fluid as a vital sign for fetal wellbeing. AJUM.

2013;16(2):62–70.

12. Magann EF, Chauhan SP, Bofill JA, Martin JN. Comparability of the amniotic fluid index and single deepest pocket measurements in clinical practice. Aust New Zeal J Obstet Gynaecol. 2003;43(1):75–7.

13. Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket: A meta-analysis of randomized controlled trials. Int J Gynecol Obstet.

International Federation of Gynecology and Obstetrics; 2009;104(3):184–8.

14. Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR. Ultrasound evaluation of amniotic fluid volume. II. The relationship of increased amniotic fluid volume to perinatal outcome. Am J Obstet Gynecol. 1984;150(3):250–4.

15. Phelan JP, Smith CV BP, Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks’ gestation. J Reprod Med. 1987;32(7):540–2.

16. Akhter H, Guha K, Daisy KP. Amniotic Fluid Index in High Risk Pregnancies and Pregnancy Outcome. Dinajpur Med Col J. 2010;3(1):1–5.

17. Magann EF, Chauhan SP, Whitworth NS, Isler C, Wiggs C, Morrison JC. Subjective Versus Objective Evaluation of Amniotic Fluid Volume of Pregnancies of Less Than 24 Weeks’Gestation. J Ultrasound Med. 2001;20:191–5.

18. Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990;162(5):1168–73.

19. Magann EF, Sanderson M, Martin JN, Chauhan S. The amniotic fluid index, single deepest pocket, and two-diameter pocket in normal human pregnancy. Am J Obstet Gynecol. 2000;182(6):1581–8.

20. Shanks A, Tuuli M, Schaecher C, Odibo AO, Rampersad R. Assessing the optimal definition of oligohydramnios associated with adverse neonatal outcomes. J ultrasound

xlviii Med. 2011;30(3):303–7.

21. Rutherford SE, Phelan JP SC, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol.

1987;70(3):353–6.

22. Gumus II, Koktener A, Turhan NO. Perinatal outcomes of pregnancies with borderline amniotic fluid index. Arch Gynecol Obstet. 2007;276(1):17–9.

23. Banks EH, Miller DA. Perinatal risks associated with borderline amniotic fluid index.

Am J Obstet Gynecol. 1999;180(6):1461–3.

24. Miller DA, Rabello YA, Paul RH. The modified biophysical profile: Antepartum testing in the 1990s. Am J Obstet Gynecol. 1996;174(3):812–7.

25. Kreiser D, El-Sayed YY, Sorem KA, Chitkara U, Holbrook RH, Druzin ML.

Decreased amniotic fluid index in low-risk pregnancy. J Reprod Med. 2001;46(8):743–

6.

26. Magann EF, Chauhan SP, Hitt WC, Dubil EA, Morrison JC. Borderline or marginal amniotic fluid index and peripartum outcomes: a review of the literature. J Ultrasound Med. 2011;30(4):523–8.

27. Baron C, Morgan MA, Garite TJ. The impact of amniotic fluid volume assessed intrapartum on perinatal outcome. Am J Obstet Gynecol. 1995;173(1):167–74.

28. Petrozella LN, Dashe JS, McIntire DD, Leveno KJ. Clinical significance of borderline amniotic fluid index and oligohydramnios in preterm pregnancy. Obstet Gynecol.

2011;117(2):338–42.

29. Kwon JY, Kwon HS, Kim YH, Park YW. Abnormal Doppler velocimetry is related to adverse perinatal outcome for borderline amniotic fluid index during third trimester. J Obstet Gynaecol Res. 2006;32(6):545–9.

30. Choi SR. Borderline amniotic fluid index and perinatal outcomes in the uncomplicated term pregnancy. J Matern Neonatal Med. 2015;27:1–4.

31. Magann EF, Sandlin AT, Ounpraseuth ST. Amniotic fluid and the clinical relevance of the sonographically estimated amniotic fluid volume: oligohydramnios. J ultrasound Med. 2011;30(11):1573–85.

32. Lee SM, Park SK, Shim SS, Jun JK, Park JS, Syn HC. Measurement of fetal urine production by three-dimensional ultrasonography in normal pregnancy. Ultrasound Obstet Gynecol. 2007;30(3):281–6.

33. Jamal A, Abbasi S, Mesdaghinia S. Borderline amniotic fluid index and adverse perinatal outcome. Ultrasound Obstet. 2008;32:308–97.

34. Jeng CJ, Lee JF, Wang KG, Yang YC, Lan CC. Decreased amniotic fluid index in term pregnancy. Clinical significance. J Reprod Med. 1992;37(9):789–92.

35. Luo X, Huang Y, Liang R. Analysis of 196 cases of trial of labor with borderline oligohydramnios assessed by ultrasound. Zhonghua Fu Chan Ke Za Zhi.

1998;33(10):585–7.

36. Ulker K, Ozdemir IA. The Relation of Intrapartum Amniotic Fluid Index to Perinatal Outcomes. Kafkas J Med Sci. 2011;1(1):1–7.

37. Yaqoob S, Iqbal R. Relation between Borderline Amniotic Fluid Index and Perinatal Outcome. Pakistan J Med Heal Sci. 2009;2(4):361–4.

38. Wood SL, Newton JM, Wang L, Lesser K. Borderline Amniotic Fluid Index and Its

xlix Relation to Fetal Intolerance of Labor: A 2-Center Retrospective Cohort Study. J Ultrasound Med. 2014;33(4):705–11.

39. Mahapatro AK, Jena SK, Ghose S. Pregnancy Outcome following Induction of Labour in Oligohydramnios and Borderline Liquor at Term: A Comparative Study. J Evol Med Dent Sci. 2013;2(52):10289–94.

40. Onwudiegwu U, Awowole I. Current Trends in Perinatal Mortality in Developing Countries : Nigeria as a Case Study, Perinatal Mortality. O. E, editor. Perinatal Mortality. InTech; 2012. 27-37 p.

41. Lawoyin T, Onadeko M, Asekun-Olarinmoye E. Neonatal Mortality and Perinatal Risk Factors in Rural Southwestern Nigeria: A Community-Based Prospective Study. West Afr J Med. 2010;29(1):19–23.

42. Suleiman MB, Mokuolu OA. Perinatal Mortality in a Northwestern Nigerian City: A Wake up Call. Front Pediatr. 2014;2:1–7.

43. Igberase GO. Perinatal mortality in a rural referral hospital in the Niger Delta, Nigeria.

Afr J Med Heal Sci. 2014;13:47–50.

44. Charan J, Biswas T. How to Calculate Sample Size for Different Study Designs in Medical Research? Indian J Psychol Med. 2013;35(2):121–6.

45. Alfirevic Z, Devane D, Gyte GML. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2006;3(4):1–81.

46. Khangura T, Chandraharan E. Electronic fetal heart rate monitoring: The Future. Curr Women’s Heal Rev. 2013;9:169–74.

47. Sarris I, Ioannou C, Chamberlain P, Ohuma E, Roseman F, Hoch L, et al. Intra- and interobserver variability in fetal ultrasound measurements. Ultrasound Obstet Gynecol.

2012;39(3):266–73.

48. Levin KA. Study design IV. Cohort studies. Evid Based Dent. 2006;7(2):51–2.

49. Pourhoseingholi MA, Baghestani AR, Vahedi M. How to control confounding effects by statistical analysis. Gastroenterol Hepatol from Bed to Bench. 2012;5(2):79–83.

50. Wunsch G. Confounding and control. Demogr Res. 2007;16:97–120.

51. Kamangar F. Confounding variables in epidemiologic studies: Basics and beyond.

Archives of Iranian Medicine. 2012. p. 508–16.

52. Asa T, Ib M. What it is and how to deal with it. Kidney Int [Internet]. Elsevier Masson

SAS; 2008;73(August 2007):256–60. Available from:

http://dx.doi.org/10.1038/sj.ki.5002650

53. Boulvain M, Marcoux S, Bureau M, Fortier M, Fraser W. Risks of induction of labour in uncomplicated term pregnancies. Paediatr Perinat Epidemiol. 2001;15(2):131–8.

54. Laptook AR, Shankaran S, Ambalavanan N, Carlo WA, McDonald SA, Higgins RD, et al. Outcome of Term Infants Using Apgar Scores at 10 Minutes Following Hypoxic-Ischemic Encephalopathy. Pediatrics. 2009;124(6):1619–26.

55. Archibong EJ, Etuk SJ, Sobande AA, Itan IH, Oyakhire GK. Reduction of caesarean section rate in developing countries: The way forward. Niger J Clin Pract.

2003;6(1):22–5.

56. Olofinbiyi BA, Olofinbiyi RO, Aduloju OP, Atiba BP, Olaogun OD, Ogundare OR.

Maternal views and experiences regarding repeat Caesarean section. Niger J Clin

l Pract. 2015;18(4):489–92.

57. Ameh CA, Weeks AD. The role of instrumental vaginal delivery in low resource settings. BJOG An Int J Obstet Gynaecol. 2009;116(SUPPL. 1):22–5.

58. Mylonas I, Friese K. Indications for and Risks of Elective Cesarean Section. Dtsch Ärzteblatt Int. 2015;112(29-30):489–95.

59. Benzouina S, Boubkraoui ME, Mrabet M, Chahid N, Kharbach A, El-hassani A, et al.

Fetal outcome in emergency versus elective cesarean sections at Souissi Maternity Hospital, Rabat, Morocco. Pan Afr Med J. 2016;23:1–10.

60. ACOG, AAP. The Apgar Score. Committee Opinion No. 644. 2015.

61. Kumar HM V, Kumar G V, Cheluvegowda GK, Mahesh SH. Maternal and neonatal factors among low birth weight babies: a tertiary care hospital based study. Curr Pediatr Res. 2014;18(2):73–5.

62. Negrato C, Gomes M. Low birth weight: causes and consequences. Diabetol Metab Syndr. 2013;5(1):49.

APPENDIX 1

INFORMATION SHEET

Documento similar